[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.129.96. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
February 5, 2003

Thimerosal Provision Repealed

JAMA. 2003;289(5):539. doi:10.1001/jama.289.5.539-a

A thorough review of the most widely used school-based substance abuse prevention program in the United States, Drug Abuse Resistance Education (DARE), found that the program does not prevent drug use or change students' attitudes toward drugs.

Conducted by the General Accounting Office (GAO), the research arm of Congress, the review analyzed six studies that followed students who participated in DARE, starting in fifth and sixth grades, for up to a decade. A literature review highlighted these studies because they were the only reports that included long-term comparisons of control and intervention groups.

First Page Preview View Large
First page PDF preview
First page PDF preview
×